Two stocks that Vaishali Parekh of Prabhudas Lilladher is bullish on

For HUL's stock, the bias has improved a lot and the stock has the potential to rise further

Trading Strategy
Vaishali Parekh Mumbai
1 min read Last Updated : May 11 2020 | 8:24 AM IST
BUY HINDUSTAN UNILEVER | CMP: Rs 2,089.45 | Target: Rs 2,450-2,500 | Stop Loss: Rs 1,950

The stock has witnessed a decent erosion and has bottomed out near 1,900 levels and indicated a decent bounce back with the RSI also showing a reversal and signalling 'buy'. The bias has improved a lot and the stock has the potential to rise further. Hence, we suggest to buy and accumulate this stock for an upside target of 2,450-2,500 keeping the stop loss of 1,950.

BUY SUN PHARMA | CMP: Rs 469 | Target: Rs 510-530 | Stop Loss: Rs 450

The stock has more or less indicated a higher bottom formation pattern on the daily charts and has shown signs of reversing from 448 levels. The RSI is also improving its trend. The chart looks attractive and has signified strength and has the potential to rise further in the coming days. We suggest to buy and accumulate this stock for an upside target of 510-530 keeping the stop loss of 450.
Disclaimer: The author may have positions in one or all of the above mentioned stocks. Views expressed are personal

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :MarketsMarket technicalsHindustan UnileverSun PharmaStock advice

Next Story